vinspired believes in free. We do favours for free - and by doing them we can open the doors to do more of the things we want to do. It's volunteering for the 21st century.
Guidance on changes in the management of Controlled Drugs
There have recently been a number of changes to the monitoring and inspection, prescribing, supply and record keeping requirements for Controlled Drugs. The changes, which are a mixture of legislative and good practice requirements, have led to a number of changes in day to day practice for pharmacists. This section outlines the changes, clarifies whether they are legislative or a matter of good practice and provides links to further information.
Since 1992, Arts & Business has placed over two thousand skilled business people into arts and cultural boards in the UK. We train our executives in good governance and help them understand their roles and responsibilities before facilitating an introduction with a board as a potential trustee or non executive director. Our business executives bring a range of professional and commercial expertise, enthusiasm, new networks, perspectives and ideas to boards.
This provides information on funding issues for hospices, specifically voluntary sector hospices for adults. The funding issues addressed are i. the charging of some hospices by some Trusts for the delivery of NHS support services (ie. pathology, imaging and ambulance services) and the related issue of reimbursement of hospices for pharmacy costs; and, ii. the funding of specialist registrars in palliative care
The purpose of this updated guidance is to assist primary care trusts (PCTs) in developing their plans for responding to an influenza pandemic. It is also intended to be a useful document for primary care professionals such as those working in general practice, community pharmacy and nursing, and for partner agencies providing services in the community setting.
Controlled Drugs
This page contains a range of NPC publications / resources relating to controlled drugs. Our resources aim to support the safe and effective use of controlled drugs, in line with regulatory changes and best practice.
